CATEGORIES

News and Views

LATEST

TRENDING

EDITORS CHOICE

Cumulus Neuroscience Appoints Digital Health and Pharma Executive Aman Bhatti, MD as Chief Executive Officer

Tapping AliveCor Senior Executive, Cumulus Signals Progression To A Global Healthcare Company; Dr. Bhatti To Lead Expansion of AI-Based Digital Biomarker Platform To Accelerate Patient Care and Drug Development in Neurology and Neuropsychiatry

No Tsunami of Mental Illness Accompanies Covid-19

Patients diagnosed with COVID-19 were likely to be experiencing some anxiety (worried) or depressive symptoms (sad, pessimistic) that were not serious enough to justify a diagnosis of major depression or a serious anxiety disorder.

3 Tips for Incorporating Mental Health Into Your Corporate Well-Being Program

U.S. adults reporting symptoms of anxiety disorder and/or depressive disorder rose from 11% in the first half of 2019 to more than 40% in January 2021.

Medical Innovation Still Matters—Even When the System Makes It Hard

Healthcare today is increasingly shaped by actuarial logic rather than human outcomes. Coverage decisions are driven by algorithms, prior authorizations delay care, and access...